Prevention of opportunistic infections in HIV-infected adolescents and adults. Recommendations of GESIDA/National AIDS Plan
BERENGUER J, LAGUNA F, ARRIBAS JR, ARRIZABALAGA J, CASADO JL, COSÍN J, CHAMORRO L, IRIBARREN JA, KINDELÁN JM, LÓPEZ-VÉLEZ R, LORENZO JF, LÓPEZ-ALDEGUER J, BARAIA J, GONZÁLEZ-GARCÍA J, LÓPEZ-BERNALDO DE QUIRÓS JC, LOZANO F, RIBERA E, MORENO S, MIRÓ JM, MALLOLAS J, PULIDO F
Enfermedades Infecciosas y Microbiología Clínica 2004;22(3): 160-176
Resumen del Autor:
Objective. To provide an update of guidelines from the Spanish AIDS Study Group (GESIDA) and the National AIDS Plan (PNS) committee on the prevention of opportunistic infections in adult and adolescent HIV-infected patients. Methods. These consensus recommendations have been produced by a group of experts from GESIDA and/or the PNS after reviewing the earlier document and the scientific advances in this field in the last years. The system used by the Infectious Diseases Society of America and the United States Public Health Service has been used to classify the strength and quality of the data. Results. This document provides a detailed review of the measures for the prevention of infections caused by viruses, bacteria, fungi and parasites in the context of HIV infection. Recommendations are given for preventing exposure and for primary and secondary prophylaxis for each group of pathogens. In addition, criteria are established for the withdrawal of prophylaxis in patients who
respond well to highly active antiretroviral therapy (HAART). Conclusions. HAART is the best strategy for the prevention of opportunistic infections in HIV-positive patients. Nevertheless, prophylaxis is still necessary in countries with limited economic resources, in highly immunodepressed patients until HAART achieves beneficial effects, in patients who refuse to take or who cannot take HAART, in those in whom HAART is not effective, and in the small group of infected patients with inadequate recovery of CD41 T lymphocyte counts despite good inhibition of HIV replication.
* RECUERDE. Al pulsar el enlace “Texto completo”, usted abandonará el entorno MEDES. En ese caso, la web a la que desea acceder no es propiedad de Fundación Lilly y, por tanto, ésta no se responsabiliza de los contenidos, informaciones o servicios presentes en ella, ni de la política de privacidad que aplique el sitio web de un tercero.